John Newman
Stock Analyst at Canaccord Genuity
(1.06)
# 1792
Out of 5,255 analysts
120
Total ratings
43.55%
Success rate
-3.56%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Buy | 1152 850 | 602.46 | 41.09% | 15 | Apr 22, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Buy | 14 14 | 1.55 | 803.23% | 3 | Mar 14, 2025 | |
BNTX BioNTech | Maintains: Buy | 172 172 | 101.99 | 68.09% | 8 | Mar 11, 2025 | |
ATRA Atara Biotherapeutic... | Maintains: Buy | 17 17 | 7.32 | 132.24% | 5 | Mar 11, 2025 | |
MRKR Marker Therapeutics | Initiates Coverage On: Buy | 8 | 1.26 | 534.92% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 25 | 4.96 | 404.03% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 200 200 | 10.08 | 1884.13% | 9 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 10 | n/a | n/a | 3 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 21 | 12.09 | 73.7% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 115 | 63.79 | 80.28% | 8 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 8 | 0.58 | 1279.31% | 6 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 67 | 43.52 | 53.95% | 2 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 38 43 | 11.7 | 267.52% | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 450 180 | n/a | n/a | 1 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 4.99 | 120.44% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | n/a | n/a | 5 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | 0.56 | 792.86% | 2 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 9 | n/a | n/a | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 72 | n/a | n/a | 4 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 44 | 29.51 | 49.1% | 8 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1720 400 | 4.15 | 9538.55% | 3 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 140 | n/a | n/a | 1 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 56 | n/a | n/a | 7 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 380 100 | n/a | n/a | 2 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Oct 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 210 220 | 7.78 | 2727.76% | 3 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 54 0 | n/a | n/a | 3 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 300 | n/a | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 38 | 14.68 | 158.86% | 2 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 30 | n/a | n/a | 2 | Sep 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 27 | 2.65 | 918.87% | 2 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Speculative Buy | n/a | n/a | n/a | 1 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 18 | n/a | n/a | 1 | Aug 30, 2016 |